192 related articles for article (PubMed ID: 38403632)
1. Radiomics for residual tumour detection and prognosis in newly diagnosed glioblastoma based on postoperative [
Shahzadi I; Seidlitz A; Beuthien-Baumann B; Zwanenburg A; Platzek I; Kotzerke J; Baumann M; Krause M; Troost EGC; Löck S
Sci Rep; 2024 Feb; 14(1):4576. PubMed ID: 38403632
[TBL] [Abstract][Full Text] [Related]
2. Final Results of the Prospective Biomarker Trial PETra: [
Seidlitz A; Beuthien-Baumann B; Löck S; Jentsch C; Platzek I; Zöphel K; Linge A; Kotzerke J; Petr J; van den Hoff J; Steinbach J; Krex D; Schmitz-Schackert G; Falk M; Baumann M; Krause M
Clin Cancer Res; 2021 Mar; 27(5):1351-1360. PubMed ID: 33376095
[TBL] [Abstract][Full Text] [Related]
3. Impact of [11C]methionine positron emission tomography for target definition of glioblastoma multiforme in radiation therapy planning.
Matsuo M; Miwa K; Tanaka O; Shinoda J; Nishibori H; Tsuge Y; Yano H; Iwama T; Hayashi S; Hoshi H; Yamada J; Kanematsu M; Aoyama H
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):83-9. PubMed ID: 21095072
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of intraoperative perfusion-weighted MRI and 5-aminolevulinic acid in relation to contrast-enhanced intraoperative MRI and
Pala A; Reske SN; Eberhardt N; Scheuerle A; König R; Schmitz B; Beer AJ; Wirtz CR; Coburger J
Neurosurg Rev; 2019 Jun; 42(2):471-479. PubMed ID: 29808321
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.
Piroth MD; Holy R; Pinkawa M; Stoffels G; Kaiser HJ; Galldiks N; Herzog H; Coenen HH; Eble MJ; Langen KJ
Radiother Oncol; 2011 May; 99(2):218-24. PubMed ID: 21497925
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
[TBL] [Abstract][Full Text] [Related]
7. Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.
Kawai N; Maeda Y; Kudomi N; Miyake K; Okada M; Yamamoto Y; Nishiyama Y; Tamiya T
Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):441-50. PubMed ID: 21072512
[TBL] [Abstract][Full Text] [Related]
8. A radiomics nomogram based on multiparametric MRI might stratify glioblastoma patients according to survival.
Zhang X; Lu H; Tian Q; Feng N; Yin L; Xu X; Du P; Liu Y
Eur Radiol; 2019 Oct; 29(10):5528-5538. PubMed ID: 30847586
[TBL] [Abstract][Full Text] [Related]
9. Resection of positive tissue on methionine-PET is associated with improved survival in glioblastomas.
Ohmura K; Daimon T; Ikegame Y; Yano H; Yokoyama K; Kumagai M; Shinoda J; Iwama T
Brain Behav; 2023 Dec; 13(12):e3291. PubMed ID: 37846176
[TBL] [Abstract][Full Text] [Related]
10. (18)F-Fluoroethyl-l-Thyrosine Positron Emission Tomography to Delineate Tumor Residuals After Glioblastoma Resection: A Comparison with Standard Postoperative Magnetic Resonance Imaging.
Buchmann N; Kläsner B; Gempt J; Bauer JS; Pyka T; Delbridge C; Meyer B; Krause BJ; Ringel F
World Neurosurg; 2016 May; 89():420-6. PubMed ID: 26893043
[TBL] [Abstract][Full Text] [Related]
11. Metabolic delineation of IDH1 wild-type glioblastoma surgical anatomy: how to plan the tumor extent of resection.
Altieri R; Certo F; Pacella D; Cammarata G; Garozzo M; Broggi G; Caltabiano R; Magro G; Russo G; Cosentino S; Ippolito M; Barbagallo G
J Neurooncol; 2023 Apr; 162(2):417-423. PubMed ID: 37039952
[TBL] [Abstract][Full Text] [Related]
12. Multiregional radiomics features from multiparametric MRI for prediction of MGMT methylation status in glioblastoma multiforme: A multicentre study.
Li ZC; Bai H; Sun Q; Li Q; Liu L; Zou Y; Chen Y; Liang C; Zheng H
Eur Radiol; 2018 Sep; 28(9):3640-3650. PubMed ID: 29564594
[TBL] [Abstract][Full Text] [Related]
13. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.
Grosu AL; Weber WA; Riedel E; Jeremic B; Nieder C; Franz M; Gumprecht H; Jaeger R; Schwaiger M; Molls M
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):64-74. PubMed ID: 16111573
[TBL] [Abstract][Full Text] [Related]
14. C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease and Response to Chemoradiation Therapy.
Wang Y; Rapalino O; Heidari P; Loeffler J; Shih HA; Oh K; Mahmood U
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1024-1028. PubMed ID: 29913253
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the glioblastoma phenotype by computed tomography radiomics.
Compter I; Verduin M; Shi Z; Woodruff HC; Smeenk RJ; Rozema T; Leijenaar RTH; Monshouwer R; Eekers DBP; Hoeben A; Postma AA; Dekker A; De Ruysscher D; Lambin P; Wee L
Radiother Oncol; 2021 Jul; 160():132-139. PubMed ID: 33984349
[TBL] [Abstract][Full Text] [Related]
16. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.
Hayes AR; Jayamanne D; Hsiao E; Schembri GP; Bailey DL; Roach PJ; Khasraw M; Newey A; Wheeler HR; Back M
Pract Radiat Oncol; 2018; 8(4):230-238. PubMed ID: 29730279
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a multi-modality fusion deep learning model for differentiating glioblastoma from solitary brain metastases.
Shen S; Li C; Fan Y; Lu S; Yan Z; Liu H; Zhou H; Zhang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 49(1):58-67. PubMed ID: 38615167
[TBL] [Abstract][Full Text] [Related]
18. Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study.
Miwa K; Shinoda J; Yano H; Okumura A; Iwama T; Nakashima T; Sakai N
J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1457-62. PubMed ID: 15377696
[TBL] [Abstract][Full Text] [Related]
19. FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?
Carles M; Popp I; Starke MM; Mix M; Urbach H; Schimek-Jasch T; Eckert F; Niyazi M; Baltas D; Grosu AL
Radiat Oncol; 2021 Mar; 16(1):46. PubMed ID: 33658069
[TBL] [Abstract][Full Text] [Related]
20. The value of
Garcia JR; Cozar M; Baquero M; Fernández Barrionuevo JM; Jaramillo A; Rubio J; Maida G; Soler M; Riera E
Rev Esp Med Nucl Imagen Mol; 2017; 36(2):85-90. PubMed ID: 27503425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]